Cogent Biosciences, Inc. COGT Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s change in AP?
- Cogent Biosciences, Inc. (COGT) reported change in AP of $4.24M in Q1 2026.
- How has Cogent Biosciences, Inc.'s change in AP changed year-over-year?
- Cogent Biosciences, Inc.'s change in AP increased by 98.0% year-over-year, from $2.14M to $4.24M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.